A pharmacy-based anti-coagulation management program has shown potential to improve warfarin utilisation and prevent strokes, New Zealand pharmacy leaders believe.
Speaking at last week’s Pharmacy Australia Congress, in Melbourne, Elizabeth Plant, President of the Pharmaceutical Society of New Zealand, said the program had been a resounding success, which was well-received by other health professionals.
The program, called the Community Pharmacy Anti-Coagulation Management Service (CPAMS), had provided a new model of care for pharmacy in NZ, Ms Plant said. And results from University of Auckland monitoring of the pilot program were “sensational”, she added.
“It proves community pharmacy can deliver an integrated medication management care model, and could provide a template for future services in areas such as...
This site is intended for Registered Medical Practitioners.
To make the most of Pharmacy News, you need to be logged in.